Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or imminent fundraising through debt or equity in the provided transcript. The focus appears to be on completing the acquisition and integration processes, especially related to the insurance businesses. Management indicates comfort with current capital adequacy across businesses, including Bajaj Life and Bajaj General Insurance. Dividend policies and capital utilization will be reviewed post completion of the Allianz transaction. No immediate plans to simplify structure or list life/general insurance entities in the next 2-3 years. Capital consumpti

Future growth expectations in sales/revenue/volumes?

Bajaj Finserv anticipates growth momentum post the flattish phase ending September 2025, with expected growth trajectory possibly above industry average. GST impact expected to provide a tailwind, aiding growth, with further clarity over next 2 quarters as settlement processes conclude. Retail protection segment shows consistent growth (about 70% YoY in H1), driven by multiple channels and product innovations such as term plans and annuities. Bajaj Life aims for term protection market share of around 10% in medium term (2-3 years). Bajaj General Insurance growing profitable commercial

Future growth expectations in earnings/operating earnings/profits/EPS?

Bajaj Life expects consistent margin expansion with VNB and NBM growth reflected for three consecutive quarters; margin expansion likely in the 4–6% range over medium term, excluding GST noise. Growth trajectory for Bajaj Life is set to improve post-September 2025, possibly outperforming industry growth, with GST impact seen as a transient factor over the next two quarters. Bajaj General Insurance continues to outperform the industry with ROE around 24% and combined ratio near 100%; despite some short-term underwriting losses, focus remains on profitable growth. Lending businesses (Bajaj

Bajaj FinservQ3 FY26Finance

Bajaj Finserv Q3 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,012P/E: 31.4Market Cap: ₹3.2L CrSector: Finance

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Bajaj Finserv anticipates growth momentum post the flattish phase ending September 2025, with expected growth trajectory possibly above industry average.
→GST impact expected to provide a tailwind, aiding growth, with further clarity over next 2 quarters as settlement processes conclude.
→Retail protection segment shows consistent growth (about 70% YoY in H1), driven by multiple channels and product innovations such as term plans and annuities.
→Bajaj Life aims for term protection market share of around 10% in medium term (2-3 years).
→Bajaj General Insurance growing profitable commercial lines (Fire, Marine, Engineering, Motor), with GWP growth beating market by ~5%.
→Health business targets breakeven by FY 2028, focusing on volume growth by launching new services and digital health ecosystem development.
→Growth in Group Health & Personal Accident lines dependent on market pricing and opportunities.
→Overall, management prefers steady, profitable growth with consolidation phases, avoiding aggressive forward-looking projections.

Margin guidance

Category 3

→Bajaj Life expects consistent margin expansion with VNB and NBM growth reflected for three consecutive quarters; margin expansion likely in the 4–6% range over medium term, excluding GST noise.
→Growth trajectory for Bajaj Life is set to improve post-September 2025, possibly outperforming industry growth, with GST impact seen as a transient factor over the next two quarters.
→Bajaj General Insurance continues to outperform the industry with ROE around 24% and combined ratio near 100%; despite some short-term underwriting losses, focus remains on profitable growth.
→Lending businesses (Bajaj Finance and Bajaj Housing Finance) reported strong AUM growth (~24%), healthy margins, and improved operational efficiencies, supporting robust profit growth.
→Overall, Bajaj Finserv remains cautiously optimistic on profit and earnings growth over the next 2–3 years, preferring to take a stepwise approach while adapting to regulatory and market dynamics.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any current or imminent fundraising through debt or equity in the provided transcript.
→The focus appears to be on completing the acquisition and integration processes, especially related to the insurance businesses.
→Management indicates comfort with current capital adequacy across businesses, including Bajaj Life and Bajaj General Insurance.
→Dividend policies and capital utilization will be reviewed post completion of the Allianz transaction.
→No immediate plans to simplify structure or list life/general insurance entities in the next 2-3 years.
→Capital consumption is currently primarily by Health business and AMC, with no significant immediate capital requirements.
→Overall, the company is focused on organic growth, cost optimization, and operational efficiencies rather than new fundraising.

Order book

The provided document excerpts from Bajaj Finserv Limited's November 11, 2025 update do not contain specific information about the company's current or expected order book or pending orders. The discussion primarily focuses on business performance metrics, financial results, growth strategies, health business outlook, insurance combined ratios, and operational updates across various subsidiaries such as Bajaj Life, Bajaj General Insurance, Bajaj Markets, and Bajaj Health. - No explicit mention or data on current order book or pending orders is available. - The content centers more on insurance, lending, health transactions, product mix, profitability milestones, and business growth. - Emphasis is on transactions, market share, margin expansion, and investment focus rather than order backlog. If you need detailed current or expected order book figures, please provide the relevant section or indicate if another document contains that information.

Capex plans

Yes

- Bajaj Finserv Health Limited is expanding its provider network significantly, indicating ongoing investment in health tech infrastructure and partnerships (133,000 doctors, 5,700 lab touchpoints, 16,000 hospital tie-ups). - Bajaj Markets is undergoing a system migration to Salesforce (SFDC) for frontline sales CRM, reflecting strategic investment in technology and process efficiency. - Bajaj Finserv AMC has shown rapid growth in AUM with no new capital infusion since March 2022, indicating strong capital efficiency but no current capital calls. - Bajaj Life Insurance is focused on product mix improvements, cost optimization, and digital initiatives; continued investments are implied to support growth and innovation. - Bajaj Finserv is monitoring regulatory changes (RBC norms, composite licensing, and insurance bill potential) before deciding on further capital deployment or structural changes. - Health business expects break-even by FY 2028, implying continued moderate investment till profitability is achieved. No explicit announcement of large new capex or strategic investments as of now; focus is on optimizing ongoing investments and regulatory compliance.

How does Bajaj Finserv rank vs peers in Finance?

Pro feature

1Bajaj Finserv

Rev 3Mar 3

See full Finance sector rankings

Want more stocks like Bajaj Finserv?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio